COSMOS Pharmaceutical Corporation (CSMYF)
USD 46.06
(0.0%)
USD 46.06
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | 31.5 Billion JPY | 4.56% |
| 2023 | 30.12 Billion JPY | 1.11% |
| 2022 | 29.79 Billion JPY | -10.11% |
| 2021 | 33.14 Billion JPY | 13.93% |
| 2020 | 29.09 Billion JPY | 17.43% |
| 2019 | 24.77 Billion JPY | 8.91% |
| 2018 | 22.74 Billion JPY | 2.3% |
| 2017 | 22.23 Billion JPY | 19.25% |
| 2016 | 18.64 Billion JPY | 9.18% |
| 2015 | 17.08 Billion JPY | 2.23% |
| 2014 | 16.7 Billion JPY | 7.59% |
| 2013 | 15.52 Billion JPY | 6.38% |
| 2012 | 14.59 Billion JPY | 30.49% |
| 2011 | 11.18 Billion JPY | 25.11% |
| 2010 | 8.94 Billion JPY | 40.85% |
| 2009 | 6.34 Billion JPY | 13.66% |
| 2008 | 5.58 Billion JPY | 24.75% |
| 2007 | 4.47 Billion JPY | 13.98% |
| 2006 | 3.92 Billion JPY | 52.13% |
| 2005 | 2.58 Billion JPY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 FY | 31.5 Billion JPY | 4.56% |
| 2024 Q4 | 7.76 Billion JPY | -1.75% |
| 2024 Q3 | 7.9 Billion JPY | 15.41% |
| 2024 Q1 | 8.99 Billion JPY | 12.93% |
| 2024 Q2 | 6.84 Billion JPY | -23.85% |
| 2023 FY | 30.12 Billion JPY | 1.11% |
| 2023 Q2 | 6.48 Billion JPY | -27.13% |
| 2023 Q3 | 6.78 Billion JPY | 4.58% |
| 2023 Q4 | 7.96 Billion JPY | 17.38% |
| 2023 Q1 | 8.9 Billion JPY | 12.67% |
| 2022 Q3 | 6.91 Billion JPY | 7.71% |
| 2022 FY | 29.79 Billion JPY | -10.11% |
| 2022 Q4 | 7.89 Billion JPY | 14.18% |
| 2022 Q2 | 6.42 Billion JPY | -24.93% |
| 2022 Q1 | 8.55 Billion JPY | 19.88% |
| 2021 Q1 | 10.65 Billion JPY | 10.3% |
| 2021 Q2 | 7.63 Billion JPY | -28.32% |
| 2021 Q4 | 7.13 Billion JPY | -7.53% |
| 2021 Q3 | 7.71 Billion JPY | 1.06% |
| 2021 FY | 33.14 Billion JPY | 13.93% |
| 2020 Q1 | 7.02 Billion JPY | 4.04% |
| 2020 Q4 | 9.66 Billion JPY | 29.33% |
| 2020 FY | 29.09 Billion JPY | 17.43% |
| 2020 Q3 | 7.46 Billion JPY | 51.13% |
| 2020 Q2 | 4.94 Billion JPY | -29.63% |
| 2019 FY | 24.77 Billion JPY | 8.91% |
| 2019 Q3 | 5.69 Billion JPY | 6.86% |
| 2019 Q4 | 6.75 Billion JPY | 18.46% |
| 2019 Q1 | 6.99 Billion JPY | 0.34% |
| 2019 Q2 | 5.33 Billion JPY | -23.77% |
| 2018 Q2 | 4.03 Billion JPY | -35.54% |
| 2018 FY | 22.74 Billion JPY | 2.3% |
| 2018 Q4 | 6.97 Billion JPY | 27.07% |
| 2018 Q3 | 5.48 Billion JPY | 35.99% |
| 2018 Q1 | 6.25 Billion JPY | 28.69% |
| 2017 Q1 | 6.79 Billion JPY | 30.1% |
| 2017 Q4 | 4.86 Billion JPY | -11.49% |
| 2017 FY | 22.23 Billion JPY | 19.25% |
| 2017 Q2 | 5.08 Billion JPY | -25.27% |
| 2017 Q3 | 5.49 Billion JPY | 8.13% |
| 2016 Q2 | 4.15 Billion JPY | -16.8% |
| 2016 FY | 18.64 Billion JPY | 9.18% |
| 2016 Q3 | 4.27 Billion JPY | 2.77% |
| 2016 Q1 | 4.99 Billion JPY | 0.67% |
| 2016 Q4 | 5.22 Billion JPY | 22.36% |
| 2015 FY | 17.08 Billion JPY | 2.23% |
| 2015 Q1 | 4.36 Billion JPY | 30.87% |
| 2015 Q2 | 4.26 Billion JPY | -2.15% |
| 2015 Q3 | 3.48 Billion JPY | -18.28% |
| 2015 Q4 | 4.96 Billion JPY | 42.26% |
| 2014 Q1 | 5.24 Billion JPY | 35.65% |
| 2014 FY | 16.7 Billion JPY | 7.59% |
| 2014 Q4 | 3.33 Billion JPY | -15.56% |
| 2014 Q3 | 3.94 Billion JPY | -5.57% |
| 2014 Q2 | 4.18 Billion JPY | -20.34% |
| 2013 Q4 | 3.86 Billion JPY | 6.73% |
| 2013 FY | 15.52 Billion JPY | 6.38% |
| 2013 Q1 | 5.23 Billion JPY | 37.84% |
| 2013 Q2 | 3.77 Billion JPY | -27.91% |
| 2013 Q3 | 3.62 Billion JPY | -3.97% |
| 2012 Q1 | 4.13 Billion JPY | 30.7% |
| 2012 FY | 14.59 Billion JPY | 30.49% |
| 2012 Q3 | 3.38 Billion JPY | 3.39% |
| 2012 Q2 | 3.27 Billion JPY | -20.86% |
| 2012 Q4 | 3.79 Billion JPY | 12.17% |
| 2011 FY | 11.18 Billion JPY | 25.11% |
| 2011 Q4 | 3.16 Billion JPY | 26.39% |
| 2011 Q1 | 3.18 Billion JPY | 12.45% |
| 2011 Q2 | 2.33 Billion JPY | -26.67% |
| 2011 Q3 | 2.5 Billion JPY | 7.42% |
| 2010 Q2 | 2.43 Billion JPY | -2.99% |
| 2010 Q1 | 2.5 Billion JPY | 12.97% |
| 2010 Q4 | 2.82 Billion JPY | 65.77% |
| 2010 FY | 8.94 Billion JPY | 40.85% |
| 2010 Q3 | 1.7 Billion JPY | -29.88% |
| 2009 Q2 | 1.33 Billion JPY | 0.0% |
| 2009 Q4 | 2.22 Billion JPY | 71.69% |
| 2009 FY | 6.34 Billion JPY | 13.66% |
| 2009 Q3 | 1.29 Billion JPY | -3.0% |
| 2008 FY | 5.58 Billion JPY | 24.75% |
| 2007 FY | 4.47 Billion JPY | 13.98% |
| 2006 FY | 3.92 Billion JPY | 52.13% |
| 2005 FY | 2.58 Billion JPY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | -261.11 USD | 12064647183.605% |
| Allstar Health Brands, Inc. | -215.75 Thousand USD | 14601258.749% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 624.14 Million USD | -4947.192% |
| Café Serendipity Holdings, Inc. | -1.43 Million USD | 2195217.532% |
| Decision Diagnostics Corp. | - USD | -Infinity% |
| Health Advance Inc. | -47.57 Thousand USD | 66222509.081% |
| HealthWarehouse.com, Inc. | -1.62 Million USD | 1942653.401% |
| LIGAND PHARMACEUTICAL INC | 9.82 Million USD | -320661.633% |
| MedGen, Inc. | -15.54 USD | 202715572815.573% |
| Omni Health, Inc. | 405.52 Thousand USD | -7768197.495% |
| Oxford Investments Holdings Inc. | -342.3 Thousand USD | 9203057.614% |
| Pineapple, Inc. | -1.47 Million USD | 2132018.822% |
| ScripsAmerica, Inc. | -3.8 Million USD | 827509.632% |